Compare CACI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CACI | SNN |
|---|---|---|
| Founded | 1962 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 14.0B |
| IPO Year | 1979 | 1999 |
| Metric | CACI | SNN |
|---|---|---|
| Price | $618.69 | $33.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 4 |
| Target Price | ★ $614.18 | $32.83 |
| AVG Volume (30 Days) | 215.7K | ★ 583.8K |
| Earning Date | 10-22-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 2.20% |
| EPS Growth | 12.06 | ★ 59.91 |
| EPS | ★ 22.62 | 0.56 |
| Revenue | ★ $8,858,558,000.00 | $5,944,000,000.00 |
| Revenue This Year | $10.71 | $7.85 |
| Revenue Next Year | $5.73 | $5.43 |
| P/E Ratio | ★ $27.28 | $28.67 |
| Revenue Growth | ★ 12.61 | 5.35 |
| 52 Week Low | $318.60 | $23.69 |
| 52 Week High | $632.77 | $38.79 |
| Indicator | CACI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 70.21 | 42.94 |
| Support Level | $585.98 | $31.95 |
| Resistance Level | $632.77 | $33.56 |
| Average True Range (ATR) | 16.10 | 0.40 |
| MACD | 0.21 | 0.10 |
| Stochastic Oscillator | 71.70 | 77.42 |
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.